Last reviewed · How we verify

NCT05860686: RITOR

Does Post-operative Rinsing With a Monoject Syringe Result in as Much Post-operative Pain After Surgical Removal of Lower Impact Third Molars as no Post-operative Rinsing: a Randomized Controlled Equivalence Trial

Status unknown NA Last updated 16 May 2023
What this trial tests

NA trial testing Monoject syringe in Third Molar in 150 participants. Status unknown.

Timeline
1 June 2023
Primary endpoint
31 December 2023
1 May 2024

Quick facts

Lead sponsorIsala
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment150
Start date1 June 2023
Primary completion31 December 2023
Estimated completion1 May 2024

Drugs / interventions tested

Conditions studied

Sponsor

Isala — full company profile →

Who can join

Adults 18 to 40, any sex, with Third Molar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Many authors have advocated different methods of treating alveolar osteitis. Despite many years of research, however, little progress has been made and so a study with large enough sample and standard outcome measures is warranted. Goal of this study is assess the effect of postoperative use of a monoject syringe on postoperative complaints after surgical removal of a lower third molar.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Third Molar

Currently open trials in the same condition.

Other Isala trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05860686.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing